drugset
drugset / Trial / NCT00567424

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

NCT00567424 ↗

Phase 2 Withdrawn GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Study to determine drug interactions between GW273225 and the anticonvulsants valproate, carbamazepine or phenytoin

Timeline

Start
2006-07
Primary completion
2008-03
Completion
2008-03

Outcome

Outcome not reported

Stopped: “No longer viable”

Drugs

EvaluationDrugModalityDoseRoute
Subject GW273225 Unknown — —

Indications

epilepsy